Osaic Holdings
TELO icon

Osaic Holdings’s Telomir Pharmaceuticals TELO Stock Holding History

Osaic Holdings’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.5K Buy
35,795
+2,000
+6% +$2.55K ﹤0.01% 5283
2025
Q4 		$44.9K Buy
33,795
+9,285
+38% +$13.4K ﹤0.01% 5301
2025
Q3 		$32.5K Buy
24,510
+3,550
+17% +$5.35K ﹤0.01% 5594
2025
Q2 		$26.2K Buy
20,960
+4,880
+30% +$11.3K ﹤0.01% 5508
2025
Q1 		$51.9K Buy
16,080
+9,797
+156% +$42.8K ﹤0.01% 4690
2024
Q4 		$25.9K Buy
6,283
+4,305
+218% +$20.3K ﹤0.01% 5167
2024
Q3 		$12.7K Buy
1,978
+978
+98% +$4.77K ﹤0.01% 5666
2024
Q2 		$4.81K Buy
1,000
+400
+67% +$2.5K ﹤0.01% 6194
2024
Q1 		$3.09K Buy
+600
New +$4.53K ﹤0.01% 6303

Other funds holding TELO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

Osaic Holdings's TELO Position: Q1 2026 in Review

Osaic Holdings increased its Telomir Pharmaceuticals (TELO) stake by 5.9% in Q1 2026, buying an estimated $2.55K and bringing the position to 35,795 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5283.

Osaic Holdings first reported a position in TELO in Q1 2024 and has held it in 9 quarters since. The position peaked at $51.9K in Q1 2025. 27 funds tracked by Wall St. Rank hold TELO as of Q1 2026.

  • Osaic Holdings held 35,795 shares of Telomir Pharmaceuticals worth $46.5K as of Q1 2026.
  • Osaic Holdings bought 2,000 Telomir Pharmaceuticals shares in Q1 2026, an estimated $2.55K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5283 holding.
  • Osaic Holdings first reported a position in Telomir Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Osaic Holdings's Telomir Pharmaceuticals position peaked at $51.9K in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.